Percutaneous closure of window-type patent ductus arteriosus: using the CardioSEAL and STARFlex devices.
Transcatheter closure of patent ductus arteriosus is routinely performed using various devices. After the withdrawal of the Rashkind umbrella device from the market, the wide window-type patent ductus arteriosus has been difficult to close percutaneously. Two patients with this condition are presented: a 17-year-old man and a 62-year-old woman with short (4.5- and 5.2-mm-diameter, respectively) ductus. We successfully implanted a 17-mm CardioSEAL device in the 1st patient and a 23-mm STARFlex in the 2nd, with no residual shunt at follow-up (22 and 8 months, respectively). Although these devices (which follow the general design of the Rashkind umbrella) are usually applied to atrial septal defect closure, we believe that CardioSEAL and STARFlex implants could be the treatment of choice in percutaneous treatment.of window-type patent ductus arteriosus.
Bialkowski
Jacek
J
Congenital Heart Disease & Pediatric Cardiology Department, Silesian Center for Heart Disease, Zabrze, Poland. jabi_med@priv4.onet.pl
Szkutnik
Malgorzata
M
Kusa
Jacek
J
Stein
Joerg
J
D000293:Adolescent; D006328:Cardiac Catheterization / Q000295:instrumentation*; D004374:Ductus Arteriosus, Patent / Q000628:therapy*; D004621:Embolization, Therapeutic / Q000295:instrumentation*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged